國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Genomics-driven healthcaretrends in ...

Pathak, Yashwant.

Genomics-driven healthcaretrends in disease prevention and treatment /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Genomics-driven healthcareedited by Yashwant Pathak.
其他題名:	trends in disease prevention and treatment /
其他作者:	Pathak, Yashwant.
出版者:	Singapore :Springer Singapore :2018.
面頁冊數:	xv, 409 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Pharmacogenomics.
電子資源:	http://dx.doi.org/10.1007/978-981-10-7506-3
ISBN:	9789811075063$q(electronic bk.)

Genomics-driven healthcaretrends in disease prevention and treatment /
Genomics-driven healthcaretrends in disease prevention and treatment /[electronic resource] :edited by Yashwant Pathak. - Singapore :Springer Singapore :2018. - xv, 409 p. :ill. (some col.), digital ;24 cm.

Chapter 1. Rethinking drug discovery and targeting after the genomic revolution -- Chapter 2. Living between sickness and health: Where is the human genome leading us? -- Chapter 3. Pharmacogenomics: Setting Newer Paradigms of Genetics in Therapy and Medicine -- Chapter 4. Bioinformatics and Pharmacogenomics: Tools to Understand and Accelerate Infectious Disease Control -- Chapter 5. Race and Ethnicity - Understanding Difference in the Genome Era -- Chapter 6. The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases -- Chapter 7. Impact of genomics on drug discovery and clinical medicine -- Chapter 8. Genomics and drug transporters and application in drug discovery, delivery and development -- Chapter 9. Genomics and drug metabolizing enzymes its application in Drug delivery: Evaluating the influence of the microbiome -- Chapter 10. Essentials of Genomics in the Continuum of Translational Research -- Chapter 11. Charting a course for genomic medicine from base pair to bedside -- Chapter 12. Pharmacogenomics and pharmacoepigenomics: impact on therapeutic strategies -- Chapter 13. Clinical Pharmacogenomics and Personalized Medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction -- Chapter 14. Epigenetic Patterns/Therapies associated with Genetic Disorders -- Chapter 15. Neurodegenerative disease conditions and genomic treatment for better health -- Chapter 16. Recent Trends in -Omics based methods and techniques for Lung Diseases prevention -- Chapter 17. Impact of Genomics on Personalization of Breast Cancer Care -- Chapter 18. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions.

This book evaluates trends arising in "-Omics" sciences in terms of their current and potential future application to therapeutic design and understanding of disease. Chapters consider the impact of pharmacogenomics and bioinformatics on drug development, as well as trends in genomics, as applied to understanding of neurodegenerative and lung disease, psychiatry and oncology. Following the genome studies released in early part of this century, the advent of the -Omics sciences (genomics and pharmacogenomics, proteomics, metabolomics, transcriptomics) has seen the expansion of a vast knowledgebase with utility in preventing and treating disease, and improving health for all. Bioinformatics and improved pharmacogenetic understanding forge a path for improved drug discovery and design methods accounting for differences in delivery and disposition across populations.

ISBN: 9789811075063$q(electronic bk.)

Standard No.: 10.1007/978-981-10-7506-3doiSubjects--Topical Terms:

211097
Pharmacogenomics.

LC Class. No.: RM301.3.G45 / G466 2018

Dewey Class. No.: 615.7

Genomics-driven healthcaretrends in disease prevention and treatment /
LDR:03557nmm a2200313 a 4500 001 540375
003 DE-He213
005 20181227132043.0
006 m d
007 cr nn 008maaau
008 190308s2018 si s 0 eng d
020 $a 9789811075063$q(electronic bk.)
020 $a 9789811075056$q(paper)
024 7 $a 10.1007/978-981-10-7506-3 $2 doi
035 $a 978-981-10-7506-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.3.G45 $b G466 2018
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.7 $2 23
090 $a RM301.3.G45 $b G335 2018
245 0 0 $a Genomics-driven healthcare $h [electronic resource] : $b trends in disease prevention and treatment / $c edited by Yashwant Pathak.
260 $a Singapore : $b Springer Singapore : $b Imprint: Adis, $c 2018.
300 $a xv, 409 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. Rethinking drug discovery and targeting after the genomic revolution -- Chapter 2. Living between sickness and health: Where is the human genome leading us? -- Chapter 3. Pharmacogenomics: Setting Newer Paradigms of Genetics in Therapy and Medicine -- Chapter 4. Bioinformatics and Pharmacogenomics: Tools to Understand and Accelerate Infectious Disease Control -- Chapter 5. Race and Ethnicity - Understanding Difference in the Genome Era -- Chapter 6. The Food Metabolome and Novel Dietary Biomarkers Associated with Diseases -- Chapter 7. Impact of genomics on drug discovery and clinical medicine -- Chapter 8. Genomics and drug transporters and application in drug discovery, delivery and development -- Chapter 9. Genomics and drug metabolizing enzymes its application in Drug delivery: Evaluating the influence of the microbiome -- Chapter 10. Essentials of Genomics in the Continuum of Translational Research -- Chapter 11. Charting a course for genomic medicine from base pair to bedside -- Chapter 12. Pharmacogenomics and pharmacoepigenomics: impact on therapeutic strategies -- Chapter 13. Clinical Pharmacogenomics and Personalized Medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction -- Chapter 14. Epigenetic Patterns/Therapies associated with Genetic Disorders -- Chapter 15. Neurodegenerative disease conditions and genomic treatment for better health -- Chapter 16. Recent Trends in -Omics based methods and techniques for Lung Diseases prevention -- Chapter 17. Impact of Genomics on Personalization of Breast Cancer Care -- Chapter 18. Pharmacogenomics: a new approach for preventing severe cutaneous adverse drug reactions.
520 $a This book evaluates trends arising in "-Omics" sciences in terms of their current and potential future application to therapeutic design and understanding of disease. Chapters consider the impact of pharmacogenomics and bioinformatics on drug development, as well as trends in genomics, as applied to understanding of neurodegenerative and lung disease, psychiatry and oncology. Following the genome studies released in early part of this century, the advent of the -Omics sciences (genomics and pharmacogenomics, proteomics, metabolomics, transcriptomics) has seen the expansion of a vast knowledgebase with utility in preventing and treating disease, and improving health for all. Bioinformatics and improved pharmacogenetic understanding forge a path for improved drug discovery and design methods accounting for differences in delivery and disposition across populations.
650 0 $a Pharmacogenomics. $3 211097
650 0 $a Medical genetics. $3 194842
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Health Promotion and Disease Prevention. $3 274213
700 1 $a Pathak, Yashwant. $3 520484
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-7506-3
950 $a Biomedical and Life Sciences (Springer-11642)